| Related Articles |
Notch Inhibitor Shows Modest Efficacy.
Cancer Discov. 2016 Dec 14;
Authors:
Abstract
Data from a phase I study indicate that LY3039478 is modestly effective against a range of advanced or metastatic cancers. The investigational Notch-signaling inhibitor induced partial responses and stable disease in patients with breast cancer and rare malignancies such as adenoid cystic carcinoma and leiomyosarcoma.
PMID: 27974417 [PubMed - as supplied by publisher]
http://ift.tt/2hBrInJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου